This article was originally published in The Gray Sheet
Executive SummaryCombined ultrasound and coronary balloon angioplasty catheters Oracle and Oracle Micro will be reviewed by FDA's circulatory system devices panel on April 12, according to the firm. A premarket approval application was submitted for Oracle in March 1992, and a PMA for Oracle Micro was filed in April 1992.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.